Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase 2 Study of aTezolizumab, bevAcizumab, and Cobinetin... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase 2 Study of aTezolizumab, bevAcizumab, and Cobinetinib (TACo) in patients (pts) with PD1 refractory metastatic brain metastases (MBM)
0
Authors
Elizabeth Burton
15 more
Elizabeth Burton
•
Isabella Glitza
13 more
•
Hussein Tawbi
Published
January 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
EJC Skin Cancer
Topics
Medicine
Materials Science
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.ejcskn.2024.100160
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
EJC Skin Cancer
Topics
Medicine
Materials Science
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.ejcskn.2024.100160
License
CC-BY-NC-ND
